https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2024-10275&loc=0&rl=2&tid=PrE1702
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC...
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
non interventional studyprospectivecomparing
https://www.mdpi.com/2072-6694/15/18/4436
COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected...
Combined BRAF/MEK-inhibition constitutes a relevant treatment option for BRAF-mutated advanced melanoma. The prospective, non-interventional COMBI-r study...
non interventional study